Al Ansari Exchange Donates AED 10 Million to Al Jalila Foundation to Support the “Hamdan Bin Rashid Cancer Charity Hospital”

40

In line with its humanitarian responsibility and as part of its Corporate Social Responsibility (CSR) initiatives, Al Ansari Exchange today announced donating AED 10 million to Al Jalila Foundation to support the “Hamdan Bin Rashid Cancer Charity Hospital”. The state-of-the-art comprehensive cancer facility will open its doors towards the end of 2023 to help cancer patients in need.

Mohamed A. Al Ansari, Chairman of Al Ansari Exchange, said: “We continue to support Al Jalila Foundation as part of our strategic direction and long-term partnerships to help our communities and society at large.  We are proud to contribute to this project which we are confident will be of great benefit not just for the residents of the UAE but regionally as well. 

The “Hamdan Bin Rashid Cancer Charity Hospital” is a well fitting tribute to memorialize and build on the work of the late Sheikh Hamdan Bin Rashid who will always be remembered for his humanitarian services that continue to touch millions of lives around the world.”

Dr. Abdulkareem Sultan Al Olama, CEO of Al Jalila Foundation, said“Donor support is an integral part of our success in developing the Hamdan Bin Rashid Cancer Charity Hospital and we are grateful for donors like Al Ansari Exchange who are committed to helping us realise our vision.” Al Olama added: “Their contribution to the hospital will make a real difference in our community by providing quality cancer care to patients who would otherwise be unable to access treatment. The first comprehensive cancer charity hospital in Dubai will become a beacon of hope to patients and their families.”

Upon completion, the “Hamdan Bin Rashid Cancer Charity Hospital” will cover 50,000 square meters, have a 250-bed capacity hospital and is scheduled to treat 30,000 patients a year. Approximately 4,500 new cases of cancer, one of the leading causes of deaths, are reported every year in the UAE.  Reducing the number of deaths caused by cancer is one of the key performance indicators of the pillar of world-class healthcare of the UAE National Agenda.

About Al Ansari Exchange:

Al Ansari Exchange, a leading exchange company in the UAE with the largest branch network, started as an offshoot of a flourishing general trading business by the Al Ansari family almost 60 years ago. Al Ansari Exchange was established primarily to meet the foreign exchange and remittance needs of their trading partners and customers at a time when formal banking was yet to be established in the Country.

With the gradual evolution and semblance of banking in the mid-1960s, the first branch was opened in Abu Dhabi in 1966. From there on the company has made quick strides and progressed to emerge as one of the largest and most popular exchange companies in the UAE. Al Ansari Exchange is rated “5A1” by “Dun & Bradstreet”, an internationally recognized credit rating agency, in addition to being licensed and regulated by the Central Bank of the UAE.

Today, Al Ansari Exchange boasts a network of over 199 branches, employing over 3,000 multilingual staff who cater to more than 2.5 million customers every month with fast, reliable and efficient service at very competitive rates. The company also conducts 100,000 transactions per day and commands 36% market share among exchange houses in the UAE with over AED 40.2 billion transferred through its network in 2020.

 While the UAE remains Al Ansari Exchange’s core market, the company will continue to strengthen its presence to be an international brand. As of now, the company maintains a key presence in Kuwait with 9 branches and plans to pursue its ambition of global expansion in the long term.

About Al Jalila Foundation:

Al Jalila Foundation, a global healthcare philanthropic organisation dedicated to transforming lives, was founded by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President, and Prime Minister of the United Arab Emirates (UAE) and Ruler of Dubai in April 2013, to position Dubai and the UAE at the forefront of medical innovation. 

Al Jalila Foundation supports medical treatment for individuals unable to afford quality healthcare; provides scholarships to nurture a home-grown generation of medical professionals and supports ground-breaking research that addresses health challenges prevalent in the region: cancer, cardiovascular diseases, diabetes, obesity and mental health. In response to the COVID-19 global pandemic, Al Jalila Foundation expanded its research portfolio to address the coronavirus and other emerging diseases effecting mankind.

In August 2020, His Highness Sheikh Mohammed inaugurated the Mohammed Bin Rashid Medical Research Institute, a AED 300 million multi-disciplinary research centre established by Al Jalila Foundation to lead as a beacon of hope for the UAE and the Arab region.

Al Jalila Foundation is named after Her Highness Sheikha Al Jalila Bint Mohammed Bin Rashid Al Maktoum, the daughter of His Highness Sheikh Mohammed Bin Rashid Al Maktoum.

Al Jalila Foundation is one of 33 member organisations under the Mohammed Bin Rashid Al Maktoum Global Initiatives which embodies the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum to improve the Arab world through humanitarian, developmental and community work.